Cite
HARVARD Citation
Jangal, M. et al. (n.d.). Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?. Expert opinion on therapeutic targets. pp. 565-578. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jangal, M. et al. (n.d.). Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?. Expert opinion on therapeutic targets. pp. 565-578. [Online].